News headlines about Quotient Limited (NASDAQ:QTNT) have trended somewhat positive on Monday, Accern Sentiment Analysis reports. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Quotient Limited earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave media stories about the company an impact score of 46.7179822640979 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Several research firms have commented on QTNT. BTIG Research reiterated a “buy” rating and set a $12.00 price objective on shares of Quotient Limited in a research report on Thursday, August 31st. Jefferies Group LLC lowered their price objective on shares of Quotient Limited from $15.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, November 1st. Zacks Investment Research upgraded shares of Quotient Limited from a “sell” rating to a “hold” rating in a research report on Tuesday, October 10th. Finally, ValuEngine lowered shares of Quotient Limited from a “sell” rating to a “strong sell” rating in a research report on Friday, September 1st.

Shares of Quotient Limited (QTNT) traded up $0.05 on Monday, hitting $4.71. 156,300 shares of the stock traded hands, compared to its average volume of 418,751. Quotient Limited has a 1-year low of $3.22 and a 1-year high of $7.74. The company has a current ratio of 1.36, a quick ratio of 0.86 and a debt-to-equity ratio of -5.17.

In other news, insider D J. Paul E. Cowan sold 54,460 shares of the stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $4.06, for a total value of $221,107.60. Following the sale, the insider now owns 26,666 shares of the company’s stock, valued at $108,263.96. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider D J. Paul E. Cowan sold 30,197 shares of the firm’s stock in a transaction dated Monday, October 16th. The stock was sold at an average price of $4.92, for a total transaction of $148,569.24. Following the completion of the transaction, the insider now directly owns 26,666 shares in the company, valued at approximately $131,196.72. The disclosure for this sale can be found here. In the last three months, insiders sold 375,197 shares of company stock worth $1,639,728. Insiders own 29.00% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This report was reported by Watch List News and is the sole property of of Watch List News. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at

Quotient Limited Company Profile

Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market.

Insider Buying and Selling by Quarter for Quotient Limited (NASDAQ:QTNT)

Receive News & Ratings for Quotient Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient Limited and related companies with Analyst Ratings Network's FREE daily email newsletter.